0001387131-15-003566.txt : 20151208
0001387131-15-003566.hdr.sgml : 20151208
20151208143721
ACCESSION NUMBER: 0001387131-15-003566
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151207
FILED AS OF DATE: 20151208
DATE AS OF CHANGE: 20151208
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ohr Pharmaceutical Inc
CENTRAL INDEX KEY: 0001173281
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465622433
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 800 THIRD AVENUE
STREET 2: 11TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (212) 682-8452
MAIL ADDRESS:
STREET 1: 800 THIRD AVENUE
STREET 2: 11TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER COMPANY:
FORMER CONFORMED NAME: BBM HOLDINGS, INC.
DATE OF NAME CHANGE: 20070402
FORMER COMPANY:
FORMER CONFORMED NAME: PRIME RESOURCE INC
DATE OF NAME CHANGE: 20020513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Slakter Jason Scott
CENTRAL INDEX KEY: 0001630109
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35963
FILM NUMBER: 151275428
MAIL ADDRESS:
STREET 1: 57 MEADOW WOODS ROAD
CITY: GREAT NECK
STATE: NY
ZIP: 11020
4
1
slakter-form4_120715.xml
OWNERSHIP DOCUMENT
X0306
4
2015-12-07
0
0001173281
Ohr Pharmaceutical Inc
OHRP
0001630109
Slakter Jason Scott
C/O OHR PHARMACEUTICALS INC.
800 THIRD AVENUE, 11TH FLOOR
NEW YORK
NY
10022
1
1
0
0
Chief Executive Officer
Common Stock, par value $0.0001 per share
2015-12-07
4
P
0
100
4.13
A
506246
D
Common Stock, par value $0.0001 per share
2015-12-07
4
P
0
1200
4.12
A
507446
D
Common Stock, par value $0.0001 per share
2015-12-07
4
P
0
100
4.10
A
507546
D
Common Stock, par value $0.0001 per share
2015-12-07
4
P
0
300
4.07
A
507846
D
Common Stock, par value $0.0001 per share
2015-12-07
4
P
0
300
4.05
A
508146
D
Common Stock, par value $0.0001 per share
2015-12-07
4
P
0
800
4.02
A
508946
D
Common Stock, par value $0.0001 per share
2015-12-07
4
P
0
200
4.00
A
509146
D
The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2015.
/s/ Jason Scott Slakter
2015-12-08